Although CEA was often falsely elevated in smokers and in patients with restrictive or obstructive pulmonary diseases [27–29], abnormally elevated CEA levels were reported in 30-70% of patients with NSCLC. Here, CEACAM5 is linked to non-small cell lung carcinoma.